Cargando…
Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study
[Image: see text]
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804538/ https://www.ncbi.nlm.nih.gov/pubmed/35762264 http://dx.doi.org/10.1111/bjd.21722 |
| _version_ | 1784862132930609152 |
|---|---|
| author | Vonk, Jasper de Wit, Jaron G. Voskuil, Floris J. Koldijk, Marjolein Rácz, Emőke Hooghiemstra, Wouter T.R. Doff, Jan J. Diercks, Gilles F.H. van Dam, Gooitzen M. Witjes, Max J.H. de Visscher, Sebastiaan A.H.J. |
| author_facet | Vonk, Jasper de Wit, Jaron G. Voskuil, Floris J. Koldijk, Marjolein Rácz, Emőke Hooghiemstra, Wouter T.R. Doff, Jan J. Diercks, Gilles F.H. van Dam, Gooitzen M. Witjes, Max J.H. de Visscher, Sebastiaan A.H.J. |
| author_sort | Vonk, Jasper |
| collection | PubMed |
| description | [Image: see text] |
| format | Online Article Text |
| id | pubmed-9804538 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98045382023-01-03 Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study Vonk, Jasper de Wit, Jaron G. Voskuil, Floris J. Koldijk, Marjolein Rácz, Emőke Hooghiemstra, Wouter T.R. Doff, Jan J. Diercks, Gilles F.H. van Dam, Gooitzen M. Witjes, Max J.H. de Visscher, Sebastiaan A.H.J. Br J Dermatol Correspondence [Image: see text] John Wiley and Sons Inc. 2022-08-02 2022-11 /pmc/articles/PMC9804538/ /pubmed/35762264 http://dx.doi.org/10.1111/bjd.21722 Text en © 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Vonk, Jasper de Wit, Jaron G. Voskuil, Floris J. Koldijk, Marjolein Rácz, Emőke Hooghiemstra, Wouter T.R. Doff, Jan J. Diercks, Gilles F.H. van Dam, Gooitzen M. Witjes, Max J.H. de Visscher, Sebastiaan A.H.J. Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study |
| title | Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study |
| title_full | Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study |
| title_fullStr | Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study |
| title_full_unstemmed | Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study |
| title_short | Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study |
| title_sort | fluorescence molecular imaging using cetuximab‐800cw in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804538/ https://www.ncbi.nlm.nih.gov/pubmed/35762264 http://dx.doi.org/10.1111/bjd.21722 |
| work_keys_str_mv | AT vonkjasper fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT dewitjarong fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT voskuilflorisj fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT koldijkmarjolein fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT raczemoke fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT hooghiemstrawoutertr fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT doffjanj fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT diercksgillesfh fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT vandamgooitzenm fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT witjesmaxjh fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy AT devisschersebastiaanahj fluorescencemolecularimagingusingcetuximab800cwincutaneoussquamouscellcarcinomasurgeryaproofofconceptstudy |